Nanoform Finland Oyj (STO:NANOFS)
Sweden · Delayed Price · Currency is SEK 8.82
-0.20 (-2.22%)
At close: Feb 9, 2026
Nanoform Finland Oyj Market Cap
Nanoform Finland Oyj has a market cap or net worth of 750.8 million as of February 10, 2026. Its market cap has decreased by -37.77% in one year.
Market Cap
750.80M
Enterprise Value
506.98M
Revenue
42.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.82
Market Cap Chart
Since June 4, 2020, Nanoform Finland Oyj's market cap has decreased from 3.28B to 750.80M, a decrease of -77.14%. That is a compound annual growth rate of -22.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 750.80M | -30.84% |
| Dec 30, 2025 | 1.09B | -20.21% |
| Dec 30, 2024 | 1.36B | -1.83% |
| Dec 29, 2023 | 1.39B | -50.39% |
| Dec 30, 2022 | 2.79B | -42.85% |
| Dec 30, 2021 | 4.89B | 2.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioInvent International AB | 1.73B |
| Genovis AB (publ.) | 1.35B |
| Cantargia AB | 1.26B |
| SynAct Pharma AB | 1.10B |
| Xspray Pharma AB | 1.01B |
| Infant Bacterial Therapeutics AB | 770.57M |
| Oncopeptides AB | 748.58M |
| FluoGuide | 552.61M |